To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Clinical Nutrition Market size was valued at USD 14.85 billion in 2021 and is poised to grow from USD 15.6 billion in 2022 to USD 22.9 billion by 2030, growing at a CAGR of 5% in the forecast period (2023-2030).

The clinical nutrition market is relatively fragmented, with a high level of competition. Few large players, like Glanbia Plc, Pfizer Inc., and Danone Nutricia, now control the market in terms of market share. These industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability. 'Abbott Laboratories', 'B. Braun Melsungen AG', 'Danone Nutricia', 'Lonza Ltd', 'Nestle Health Science', 'Baxter International', 'Mead Johnson Nutrition Company', 'Fresenius Kabi', 'Perrigo Company', 'Ajinomoto Co., Inc.', 'GlaxoSmithKline plc', 'Pfizer Inc.', 'Nutri-Force Nutrition', 'Nutricia Advanced Medical Nutrition', 'American Regent', 'BASF SE', 'Pharmavite LLC', 'Kerry Group', 'DSM Nutritional Products', 'Royal FrieslandCampina N.V.'

The increase in the elderly population is driving the expansion of the global clinical nutrition market. As humans age, they become less active, their metabolism slows, and their energy requirements drop, as their ability to absorb and utilize nutrients degrades. Consequently, their nutritional needs increase. These are the major factors driving the demand for clinical nutrition for better energy absorption and utilization which will propel the market growth during the analysis period.

Improved healthcare infrastructure and rising demand for better healthcare present lucrative growth possibilities for the clinical nutrition market in the emerging nations of Asia-Pacific and LAMEA. In addition, the increase in the incidence of various lifestyle and chronic diseases that lead to malnutrition and dietary problems, as well as the increase in the research required for the development of medical devices for clinical nutrition of a variety of diseases such as respiratory, renal, and cancer, have boosted the demand for the clinical nutrition market.

In 2021, North America accounts for the largest share of the market and is expected to register a CAGR of 5.5% during the projected period. Continuous clinical nutrition R&D is a key trend in the clinical nutrition sector in North America. In addition, for several chronic diseases, including coronary artery disease, ischemic stroke, diabetes, and a few cancer indications. Diabetes prevalence has boosted the demand for medical nutrition therapy. In addition, the expanding demand for clinical nutrition in the pediatric sector is likely to present market participants with lucrative growth opportunities and drive the clinical nutrition market size during the analysis period.

Feedback From Our Clients

Global Clinical Nutrition Market

Product ID: SQSG30A2003